Trials / Completed
CompletedNCT03345316
Study of FFI-1010 in Pediatric Kidney Disease
Safety and Usability Evaluation Study of FFI-1010 Single Administration for Children Under 18 Years Old With Kidney Disease (Phase III Study).
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Fuji Yakuhin Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is revealing that the ratio of creatinine clearance (Ccr) to inulin clearance (Cin) measuring at the same time is more than 1.2.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FFI-1010 | Intravenous single dosing |
Timeline
- Start date
- 2017-11-01
- Primary completion
- 2019-11-01
- Completion
- 2019-11-01
- First posted
- 2017-11-17
- Last updated
- 2019-12-11
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03345316. Inclusion in this directory is not an endorsement.